Quality of life study for newly diagnosed brain germ cell tumors
Part of Brain & nervous system, Cancer clinical trials.
This study looks at how life quality changes in children and young adults after a new diagnosis of a brain germ cell tumor. It may help doctors understand which supports improve day-to-day well-being.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 3 and 21 years old
- You have a new (just diagnosed) primary germ cell tumor in the brain
- You (or a legal guardian) can give written informed consent
- Your cancer has not come back (not relapsed)
- You can follow the study plan and attend needed visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how nutrition affects the quality of life in children and teens with neurological tumors who are getting radiation therapy. It aims to help doctors better support patients during treatment.
This study asks people with neuroendocrine tumors to report how they’re doing, including quality of life and quality of care. Your answers can help doctors and hospitals understand what support works best.
This study tests a French version of a questionnaire that measures quality of life in people with meningioma. Participation involves filling out the questionnaire to help doctors better understand how the tumor affects your daily life.
This study looks at how your quality of life changes over time after being diagnosed with a brain tumor called glioma. It may help doctors better understand what support or treatments improve day-to-day well-being.
This study tests two versions of a health survey designed for children aged 5 to 16 with pneumonia, brain tumors, or immune thrombocytopenia. Children and their caregivers will fill out questionnaires to see how well the surveys measure quality of life.
This study looks at long-term health problems and quality of life in people who survived germ cell tumors after strong chemotherapy with a stem cell transplant or other standard treatments. It may help doctors understand which late side effects are most common and how to better support survivors.
Hear when a new Quality of Life trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.